NO20060369L - Metabolitter av trisykliske amider anvendbare ved inhibering av G-proteinfunksjon og fremgangsmater ved behandling av proliferaktive sykdommer - Google Patents

Metabolitter av trisykliske amider anvendbare ved inhibering av G-proteinfunksjon og fremgangsmater ved behandling av proliferaktive sykdommer

Info

Publication number
NO20060369L
NO20060369L NO20060369A NO20060369A NO20060369L NO 20060369 L NO20060369 L NO 20060369L NO 20060369 A NO20060369 A NO 20060369A NO 20060369 A NO20060369 A NO 20060369A NO 20060369 L NO20060369 L NO 20060369L
Authority
NO
Norway
Prior art keywords
methods
inhibiting
metabolites
proliferative diseases
treating proliferative
Prior art date
Application number
NO20060369A
Other languages
English (en)
Norwegian (no)
Inventor
Keith P Minor
Ronald J Doll
Anima Ghosal
Shmuel Zbaida
Swapan K Chowdhury
Kevin B Alton
Robert M Iannucci
Wenqing Feng
Tze-Ming Chan
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33563857&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20060369(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO20060369L publication Critical patent/NO20060369L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Hydrogenated Pyridines (AREA)
NO20060369A 2003-06-25 2006-01-24 Metabolitter av trisykliske amider anvendbare ved inhibering av G-proteinfunksjon og fremgangsmater ved behandling av proliferaktive sykdommer NO20060369L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48237303P 2003-06-25 2003-06-25
PCT/US2004/020032 WO2005003120A2 (en) 2003-06-25 2004-06-23 Metabolites of tricyclic amides useful for inhibition of g-protein function and methods of treatment of proliferative diseases

Publications (1)

Publication Number Publication Date
NO20060369L true NO20060369L (no) 2006-03-22

Family

ID=33563857

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060369A NO20060369L (no) 2003-06-25 2006-01-24 Metabolitter av trisykliske amider anvendbare ved inhibering av G-proteinfunksjon og fremgangsmater ved behandling av proliferaktive sykdommer

Country Status (19)

Country Link
US (1) US7271174B2 (de)
EP (1) EP1644359A2 (de)
JP (1) JP2007516179A (de)
KR (1) KR20060023141A (de)
CN (1) CN100410252C (de)
AR (1) AR044879A1 (de)
AU (1) AU2004253904A1 (de)
BR (1) BRPI0411931A (de)
CA (1) CA2525968A1 (de)
CO (1) CO5650249A2 (de)
EC (1) ECSP056248A (de)
IL (1) IL172656A0 (de)
MX (1) MXPA05013601A (de)
NO (1) NO20060369L (de)
PE (1) PE20050697A1 (de)
RU (1) RU2006101825A (de)
TW (1) TW200510396A (de)
WO (1) WO2005003120A2 (de)
ZA (1) ZA200509546B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011088126A2 (en) * 2010-01-13 2011-07-21 Eiger Biopharmaceuticals, Inc. Treatment of viral infection with prenyltransferase inhibitors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US498509A (en) 1893-05-30 Evan evans and jopin davies
WO1995000497A1 (en) 1993-06-18 1995-01-05 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
IL111235A (en) 1993-10-15 2001-03-19 Schering Plough Corp Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them
US5874442A (en) * 1995-12-22 1999-02-23 Schering-Plough Corporation Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative disease
US6239140B1 (en) * 1997-06-17 2001-05-29 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
US6576639B1 (en) * 1997-06-17 2003-06-10 Schering Corporation Compounds for the inhibition of farnesyl protein transferase
US6358968B1 (en) * 1997-06-17 2002-03-19 Schering Corporation N-substituted urea inhibitors of farnesyl-protein transferase
JP3769178B2 (ja) * 2000-09-06 2006-04-19 ヒロセ電機株式会社 光アダプタ

Also Published As

Publication number Publication date
BRPI0411931A (pt) 2006-08-15
EP1644359A2 (de) 2006-04-12
ZA200509546B (en) 2006-09-27
TW200510396A (en) 2005-03-16
WO2005003120A3 (en) 2005-03-17
PE20050697A1 (es) 2005-09-05
AR044879A1 (es) 2005-10-05
RU2006101825A (ru) 2006-07-27
MXPA05013601A (es) 2006-03-09
IL172656A0 (en) 2006-04-10
CO5650249A2 (es) 2006-06-30
US7271174B2 (en) 2007-09-18
AU2004253904A1 (en) 2005-01-13
CN1809555A (zh) 2006-07-26
CN100410252C (zh) 2008-08-13
WO2005003120A2 (en) 2005-01-13
CA2525968A1 (en) 2005-01-13
ECSP056248A (es) 2006-04-19
US20040266810A1 (en) 2004-12-30
KR20060023141A (ko) 2006-03-13
JP2007516179A (ja) 2007-06-21

Similar Documents

Publication Publication Date Title
DE69413542D1 (de) Perhydroisoindolderivate als substanz p antagonisten
NO991234L (no) Trisykliske inhibitorer av farnesylproteintransferase
PL375513A1 (en) 3-(sulfonamidoethyl)-indole derivatives for use as glucocorticoid mimetics in the treatment of inflammatory, allergic and proliferative diseases
MXPA04007414A (es) Indoles sustituidos como agonistas alfa-1.
NO20050417L (no) Azaindol kinase-inhibitorer
SE0302487D0 (sv) Novel compounds
WO2021011713A8 (en) Imidazopyrimidines as eed inhibitors and the use thereof
PL247096A1 (en) Agent for fighting against and/or preventing paralyzing effects of microorganisms and method of obtaining new derivatives of n-/2-nitrophenylo/-4-aminopyrimidines
DE602004012758D1 (de) Chinoxalinderivate als inhibitoren der neutrophilelastase und deren verwendung
KR960704852A (ko) 아졸 유도체 및 이의 약제학적 조성물 (Azole derivative and pharmaceutical composition thereof)
DK0773943T3 (da) Forbindelser, der er anvendelige som antiproliferative midler og garft-inhibitorer
NO963706L (no) Benzenkondenserte heterosykliske derivater og deres anvendelse
NO20055143L (no) Doseringsformer innbefattende AG013736
MX2025002166A (es) Compuestos y metodos para modular her2
AU2003250701A1 (en) Protein tyrosine kinase inhibitors
MX2025008428A (es) Derivados de piperidina como inhibidores de mettl3
MX2025000403A (es) Compuestos como inhibidores de myt1
CR20230218A (es) Nuevos derivados de indazol acetileno
RU94045272A (ru) Применение 2-фенил-3-ароилбензотиофенов для лечения овариального дисгенеза, задержки полового созревания или сексуального инфантелизма
NO20060369L (no) Metabolitter av trisykliske amider anvendbare ved inhibering av G-proteinfunksjon og fremgangsmater ved behandling av proliferaktive sykdommer
NO962285L (no) N-substituerte azabicykloheptan-derivater anvendt for eksempel som neuroleptika
DK0861250T3 (da) Amindin- og isothiourinstofderivater som inhibitorer for nitrogenmonoxidsyntase
EP0725068A4 (de) Indolderivate
MX2024008003A (es) Compuesto de indazol y composicion farmaceutica.
ATE209201T1 (de) Substituierte benzocycloheptapyridine derivate verwendbar als farnesyl-protein transferase inhibitoren

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application